The surgical closure of orofacial clefts is considered to impair maxillary growth and dento-alveolar development. Wound contraction and subsequent scar tissue formation, during healing of these surgical wounds, contribute largely to these growth disturbances. The potential to minimize wound contraction and subsequent scarring by clinical interventions depends on the surgeon’s knowledge of the events responsible for these phenomena. Fibroblasts initiate wound contraction, but proto-myofibroblasts and mature myofibroblasts are by far the most important cells in this process. Myofibroblasts are characterized by their cytoskeleton, which contains alpha-smooth-muscle actin. Additionally, their contractile apparatus contains bundles of actin microfilaments and associated contractile proteins, such as non-muscle myosin. This contractile apparatus is thought to be the major force-generating element involved in wound contraction. After closure of the wound, the myofibroblasts disappear by apoptosis, and a less cellular scar is formed. A reduction of contraction and scarring might be obtained by inhibition of myofibroblast differentiation, stimulation of their de-differentiation, stimulation of myofibroblast apoptosis, or impairment of myofibroblast function. In this review, we will discuss all of these possibilities, which ultimately may lead to a better outcome of cleft palate surgery.
Arnaout MA, Goodman SL, Xiong JP (2002). Coming to grips with integrin binding to ligands. Curr Opin Cell Biol14:641–651.
4.
Arora PD, McCulloch CA (1999). The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization. Am J Pathol155:2087–2099.
5.
Arora PD, Narani N, McCulloch CA (1999). The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol154:871–882.
6.
Badid C, Mounier N, Costa AM, Desmouliere A (2000). Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies. Histol Histopathol15:269–280.
7.
Balza E, Borsi L, Allemanni G, Zardi L (1988). Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett228:42–44.
8.
Bariety J, Hill GS, Mandet C, Irinopoulou T, Jacquot C, Meyrier A, et al. (2003). Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant18:1777–1784.
9.
Bodner L, Dayan D (1995). Epithelium and connective tissue regeneration during palatal wound healing in desalivated rats—a comparative study. Comp Biochem Physiol A Physiol111:415–419.
10.
Bodner L, Dayan D, Rothchild D, Hammel I (1991). Extraction wound healing in desalivated rats. J Oral Pathol Med20:176–178.
11.
Borsi L, Castellani P, Risso AM, Leprini A, Zardi L (1990). Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett261:175–178.
12.
Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstand H, et al. (1996). PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell85:863–873.
13.
Bronson RE, Argenta JG, Siebert EP, Bertolami CN (1988). Distinctive fibroblastic subpopulations in skin and oral mucosa demonstrated by differences in glycosaminoglycan content. In Vitro Cell Dev Biol24:1121–1126.
14.
Burridge K, Chrzanowska-Wodnicka M (1996). Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol12:463–518.
15.
Castor CW, Prince RK, Dorstewitz EL (1962). Characteristics of human “fibroblasts” cultivated in vitro from different anatomical sites. Lab Invest11:703–713.
16.
Chipev CC, Simon M (2002). Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. BMC Dermatol2:13.
17.
Clark RA (1996). Wound repair—overview and general considerations. In: The molecular and cellular biology of wound repair. Clark RA, editor. New York: Plenum Press, pp. 3–50.
18.
Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM (2000a). Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. J Dent Res79:1782–1788.
19.
Cornelissen AM, Stoop R, Von den Hoff HW, Maltha JC, Kuijpers-Jagtman AM (2000b). Myofibroblasts and matrix components in healing palatal wounds in the rat. J Oral Pathol Med29:1–7.
20.
Darby I, Skalli O, Gabbiani G (1990). Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest63:21–29.
21.
Darby IA, Bisucci T, Pittet B, Garbin S, Gabbiani G, Desmouliere A (2002). Skin flap-induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol197:117–127.
22.
De Wever O, Mareel M (2002). Role of myofibroblasts at the invasion front. Biol Chem383:55–67.
23.
Desmouliere A (1995). Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int19:471–476.
24.
Desmouliere A, Gabbiani G (1996). The role of the myofibroblast in wound healing and fibrocontractive diseases. In: The molecular and cellular biology of wound repair. Clark RAF, editor. New York: Plenum Press, pp. 391–413.
25.
Desmouliere A, Rubbia-Brandt L, Abdiu A, Walz T, Macieira-Coelho A, Gabbiani G (1992). Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res201:64–73.
26.
Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol122:103–111.
27.
Desmouliere A, Redard M, Darby I, Gabbiani G (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol146:56–66.
28.
Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G (1997). Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol29:19–30.
29.
Dominguez-Malagon H (1993). Proliferative disorders of myofibroblasts. Ultrastruct Pathol17:211–220.
30.
Dugina V, Alexandrova A, Chaponnier C, Vasiliev J, Gabbiani G (1998). Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res238:481–490.
31.
Dugina V, Fontao L, Chaponnier C, Vasiliev J, Gabbiani G (2001). Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci114:3285–3296.
32.
Eddy RJ, Petro JA, Tomasek JJ (1988). Evidence for the nonmuscle nature of the “myofibroblast” of granulation tissue and hypertropic scar. An immunofluorescence study. Am J Pathol130:252–260.
33.
Ehrlich HP, Krummel TM (1996). Regulation of wound healing from a connective tissue perspective. Wound Repair Regen4:203–210.
34.
Ehrlich HP, Rajaratnam JB (1990). Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell22:407–417.
35.
Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, et al. (1994). Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol145:105–113.
36.
Eyden BP (1993). Brief review of the fibronexus and its significance for myofibroblastic differentiation and tumor diagnosis. Ultrastruct Pathol17:611–622.
37.
Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. (2004). Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells22:812–822.
38.
Fesus L, Davies PJ, Piacentini M (1991). Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol56:170–177.
39.
Feugate JE, Li Q, Wong L, Martins-Green M (2002). The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol156:161–172.
40.
Ffrench-Constant C (1995). Alternative splicing of fibronectin—many different proteins but few different functions. Exp Cell Res221:261–271.
41.
Finesmith TH, Broadley KN, Davidson JM (1990). Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors. J Cell Physiol144:99–107.
42.
Fisher ER, Paulson JD, Gregorio RM (1978). The myofibroblastic nature of the uterine plexiform tumor. Arch Pathol Lab Med102:477–480.
43.
Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA, et al. (1994). Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol72:283–292.
44.
Frisch SM, Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol124:619–626.
Fujioka M, Fujii T (1997). Maxillary growth following atelocollagen implantation on mucoperiosteal denudation of the palatal process in young rabbits: implications for clinical cleft palate repair. Cleft Palate Craniofac J34:297–308.
47.
Fujisawa K, Miyamoto Y, Nagayama M (2003). Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa. J Oral Pathol Med32:358–366.
48.
Funato N, Moriyama K, Shimokawa H, Kuroda T (1997). Basic fibroblast growth factor induces apoptosis in myofibroblastic cells isolated from rat palatal mucosa. Biochem Biophys Res Commun240:21–26.
49.
Funato N, Moriyama K, Baba Y, Kuroda T (1999). Evidence for apoptosis induction in myofibroblasts during palatal mucoperiosteal repair. J Dent Res78:1511–1517.
50.
Gabbiani G (1992). The biology of the myofibroblast. Kidney Int41:530–532.
51.
Gabbiani G (1994). Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Pathol Res Pract190:851–853.
52.
Gabbiani G (1998). Evolution and clinical implications of the myofibroblast concept. Cardiovasc Res38:545–548.
53.
Gabbiani G (2003). The myofibroblast in wound healing and fibrocontractive diseases. J Pathol200:500–503.
54.
Gabbiani G, Badonnel MC (1976). Contractile events during inflammation. Agents Actions6:277–280.
55.
Gabbiani G, Ryan GB, Majne G (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia27:549–550.
56.
Gabbiani G, Le Lous M, Bailey AJ, Bazin S, Delaunay A (1976). Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study. Virchows Arch B Cell Pathol21:133–145.
57.
Gokel JM, Hubner G (1977). Occurrence of myofibroblasts in the different phases of morbus Dupuytren (Dupuytren’s contracture). Beitr Pathol161:166–175.
58.
Greenhalgh DG (1998). The role of apoptosis in wound healing. Int J Biochem Cell Biol30:1019–1030.
59.
Grinnell F (1994). Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol124:401–404.
60.
Hadden HL, Henke CA (2000). Induction of lung fibroblast apoptosis by soluble fibronectin peptides. Am J Respir Crit Care Med162:1553–1560.
61.
Hakkinen L, Uitto VJ, Larjava H (2000). Cell biology of gingival wound healing. Periodontol 200024:127–152.
62.
Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G (1989). Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med170:1595–1608.
63.
Hinz B, Gabbiani G (2003). Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol14:538–546.
64.
Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G (2001). Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol159:1009–1020.
65.
Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, Chaponnier C (2003). Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell14:2508–2519.
66.
Hormia M, Thesleff I, Perheentupa J, Pesonen K, Saxen L (1993). Increased rate of salivary epidermal growth factor secretion in patients with juvenile periodontitis. Scand J Dent Res101:138–144.
67.
Horwitz AF (1997). Integrins and health. Sci Am276:68–75.
68.
Huang NF, Zac-Varghese S, Luke S (2003). Apoptosis in skin wound healing. Wounds15:182–194.
69.
Hutson JM, Niall M, Evans D, Fowler R (1979). Effect of salivary glands on wound contraction in mice. Nature279:793–795.
70.
In de Braekt MM, van Alphen FA, Kuijpers-Jagtman AM, Maltha JC (1991). Effect of low level laser therapy on wound healing after palatal surgery in beagle dogs. Lasers Surg Med11:462–470.
71.
In de Braekt MM, van Alphen FA, Kuijpers-Jagtman AM, Maltha JC (1992). Wound healing and wound contraction after palatal surgery and implantation of poly-(L-lactic) acid membranes in beagle dogs. J Oral Maxillofac Surg50:359–364; discussion 365–366.
72.
Irwin CR, Picardo M, Ellis I, Sloan P, Grey A, McGurk M, et al. (1994). Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci107:1333–1346.
73.
Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. (2005). In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells23:699–706.
74.
Jester JV, Huang J, Petroll WM, Cavanagh HD (2002). TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp Eye Res75:645–657.
75.
Kagami H, Hiramatsu Y, Hishida S, Okazaki Y, Horie K, Oda Y, et al. (2000). Salivary growth factors in health and disease. Adv Dent Res14:99–102.
76.
Kanda T, Funato N, Baba Y, Kuroda T (2003). Evidence for fibroblast growth factor receptors in myofibroblasts during palatal mucoperiosteal repair. Arch Oral Biol48:213–221.
77.
Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB (2003). Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol29:537–544.
78.
Kornblihtt AR, Pesce CG, Alonso CR, Cramer P, Srebrow A, Werbajh S, et al. (1996). The fibronectin gene as a model for splicing and transcription studies. FASEB J10:248–257.
79.
Kremenak CR (1984). Physiological aspects of wound healing: contraction and growth. Otolaryngol Clin North Am17:437–453.
80.
Lee HG, Eun HC (1999). Differences between fibroblasts cultured from oral mucosa and normal skin: implication to wound healing. J Dermatol Sci21:176–182.
81.
Leenstra TS, Maltha JC, Kuijpers-Jagtman AM, Spauwen PH (1995). Wound healing in beagle dogs after palatal repair without denudation of bone. Cleft Palate Craniofac J32:363–369.
82.
Lekic PC, Pender N, McCulloch CA (1997). Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit Rev Oral Biol Med8:253–268.
83.
Lepekhin E, Gron B, Berezin V, Bock E, Dabelsteen E (2002). Differences in motility pattern between human buccal fibroblasts and periodontal and skin fibroblasts. Eur J Oral Sci110:13–20.
84.
Levine D, Rockey DC, Milner TA, Breuss JM, Fallon JT, Schnapp LM (2000). Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol156:1927–1935.
85.
Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L (2002). The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem277:14467–14474.
86.
Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science277:242–245.
87.
Lorena D, Uchio K, Alto Costa AM, Desmouliere A (2002). Normal scarring: importance of myofibroblasts. Wound Repair Regen10:86–92.
88.
Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S (1996). Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA93:4219–4223.
89.
Masur SK, Conors RJJ, Cheung JK, Antohi S (1999). Matrix adhesion characteristics of corneal myofibroblasts. Invest Ophthalmol Vis Sci40:904–910.
90.
McCluskey J, Martin P (1995). Analysis of the tissue movements of embryonic wound healing—DiI studies in the limb bud stage mouse embryo. Dev Biol170:102–114.
91.
Metz CN (2003). Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci60:1342–1350.
92.
Millard DR Jr (1976). Reconstructive rhinoplasty for the lower two-thirds of the nose. Plast Reconstr Surg57:722–728.
93.
Molsted K (1999). Treatment outcome in cleft lip and palate: issues and perspectives. Crit Rev Oral Biol Med10:225–239.
94.
Moulin V, Castilloux G, Auger FA, Garrel D, O’Connor-McCourt MD, Germain L (1998). Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res238:283–293.
95.
Moulin V, Auger FA, Garrel D, Germain L (2000). Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns26:3–12.
96.
Moulin V, Tam BY, Castilloux G, Auger FA, O’Connor-McCourt MD, Philip A, et al. (2001). Fetal and adult human skin fibroblasts display intrinsic differences in contractile capacity. J Cell Physiol188:211–222.
97.
Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, et al. (2003). Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol162:149–160.
98.
Nawshad A, LaGamba D, Hay ED (2004). Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol49:675–689.
99.
Nodder S, Martin P (1997). Wound healing in embryos: a review. Anat Embryol (Berl)195:215–228.
100.
Noguchi M, Suda Y, Ito S, Kohama G (2003). Dento-alveolar development in unilateral cleft lip, alveolus and palate. J Craniomaxillofac Surg31:137–141.
101.
Noguchi S, Ohba Y, Oka T (1991). Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol260:E620–E625.
102.
Nooh N, Graves DT (2003). Healing is delayed in oral compared to dermal excisional wounds. J Periodontol74:242–246.
103.
Ohshima M, Sato M, Ishikawa M, Maeno M, Otsuka K (2002). Physiologic levels of epidermal growth factor in saliva stimulate cell migration of an oral epithelial cell line, HO-1-N-1. Eur J Oral Sci110:130–136.
104.
Palaiologou AA, Yukna RA, Moses R, Lallier TE (2001). Gingival, dermal, and periodontal ligament fibroblasts express different extracellular matrix receptors. J Periodontol72:798–807.
105.
Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, et al. (2003). An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA100:6736–6740.
106.
Phan SH (2003). Fibroblast phenotypes in pulmonary fibrosis. Am J Respir Cell Mol Biol29:S87–S92.
107.
Pittet B, Rubbia-Brandt L, Desmouliere A, Sappino AP, Roggero P, Guerret S, et al. (1994). Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren’s disease: an open pilot study. Plast Reconstr Surg93:1224–1235.
108.
Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB (1999). Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol277:C1–C9.
109.
Racine-Samson L, Rockey DC, Bissell DM (1997). The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem272:30911–30917.
110.
Rizzino A, Kazakoff P, Ruff E, Kuszynski C, Nebelsick J (1988). Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. Cancer Res48:4266–4271.
111.
Ronnov-Jessen L, Petersen OW (1993). Induction of alpha-smooth muscle actin by transforming growth factor-beta1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest68:696–707.
112.
Ross RB (1987). Treatment variables affecting facial growth in complete unilateral cleft lip and palate. Cleft Palate J24:5–77.
113.
Rubbia-Brandt L, Sappino AP, Gabbiani G (1991). Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol60:73–82.
114.
Sappino AP, Schurch W, Gabbiani G (1990). Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest63:144–161.
115.
Saunders KB, D’Amore PA (1992). An in vitro model for cell-cell interactions. In Vitro Cell Dev Biol28A:521–528.
116.
Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA (2001). Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci114:3507–3516.
117.
Schmitt-Graff A, Desmouliere A, Gabbiani G (1994). Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch425:3–24.
118.
Schor SL, Ellis I, Irwin CR, Banyard J, Seneviratne K, Dolman C, et al. (1996). Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease. Oral Dis2:155–166.
119.
Schurch W, Seemayer TA, Lagace R, Gabbiani G (1984). The intermediate filament cytoskeleton of myofibroblasts: an immunofluorescence and ultrastructural study. Virchows Arch A Pathol Anat Histopathol403:323–336.
120.
Serini G, Gabbiani G (1999). Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res250:273–283.
121.
Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, et al. (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol42:873–881.
122.
Shah M, Foreman DM, Ferguson MW (1992). Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet339:213–214.
123.
Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, et al. (1999). Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol154:1115–1124.
124.
Shum DT, McFarlane RM (1988). Histogenesis of Dupuytren’s disease: an immunohistochemical study of 30 cases. J Hand Surg13:61–67.
125.
Singer II, Kawka DW, Kazazis DM, Clark RA (1984). In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol98:2091–2106.
126.
Skaleric U, Kramar B, Petelin M, Pavlica Z, Wahl SM (1997). Changes in TGF-beta1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Sci105:136–142.
127.
Sloan P (1991). Current concepts of the role of fibroblasts and extracellular matrix in wound healing and their relevance to oral implantology. J Dent19:107–109.
128.
Sottiurai VS, Fry WJ, Stanley JC (1978). Ultrastructure of medial smooth muscle and myofibroblasts in human arterial dysplasia. Arch Surg113:1280–1288.
129.
Spyrou GE, Naylor IL (2002). The effect of basic fibroblast growth factor on scarring. Br J Plast Surg55:275–282.
130.
Squier CA, Kremenak CR (1980). Myofibroblasts in healing palatal wounds of the beagle dog. J Anat130:585–594.
131.
Stephens P, Davies KJ, al-Khateeb T, Shepherd JP, Thomas DW (1996). A comparison of the ability of intra-oral and extra-oral fibroblasts to stimulate extracellular matrix re-organization in a model of wound contraction. J Dent Res75:1358–1364.
132.
Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, et al. (2001). Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol144:229–237.
133.
Sukotjo C, Lin A, Song K, Ogawa T, Wu B, Nishimura I (2003). Oral fibroblast expression of wound-inducible transcript 3.0 (wit3.0) accelerates the collagen gel contraction in vitro. J Biol Chem278:51527–51534.
134.
Szpaderska AM, Zuckerman JD, DiPietro LA (2003). Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res82:621–626.
135.
Taichman NS, Cruchley AT, Fletcher LM, Hagi-Pavli EP, Paleolog EM, Abrams WR, et al. (1998). Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab Invest78:869–875.
136.
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol3:349–363.
137.
Valentich JD, Popov V, Saada JI, Powell DW (1997). Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am J Physiol272:C1513–1524.
138.
Van Beurden HE, Snoek PA, Von den Hoff JW, Torensma R, Kuijpers-Jagtman AM (2003). Fibroblast subpopulations in intra-oral wound healing. Wound Repair Regen11:55–63.
139.
van der Flier A, Sonnenberg A (2001). Function and interactions of integrins. Cell Tissue Res305:285–298.
140.
Varedi M, Ghahary A, Scott PG, Tredget EE (1997). Cytoskeleton regulates expression of genes for transforming growth factor-beta1 and extracellular matrix proteins in dermal fibroblasts. J Cell Physiol172:192–199.
141.
Varshney AC, Sharma DN, Singh M, Sharma SK, Nigam JM (1997). Therapeutic value of bovine saliva in wound healing: a histomorphological study. Indian J Exp Biol35:535–537.
142.
Vaughan MB, Howard EW, Tomasek JJ (2000). Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res257:180–189.
143.
Von den Hoff JW, Maltha JC, Kuijpers-Jagtman AM (2005). Palatal wound healing: the effects of scarring on growth. In: Cleft lip and palate. Diagnosis and management. Berkowitz S, editor. Heidelberg: Springer Verlag (in press).
144.
Vyalov S, Desmouliere A, Gabbiani G (1993). GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch B Cell Pathol Incl Mol Pathol63:231–239.
145.
Weinzweig J, Panter KE, Pantaloni M, Spangenberger A, Harper JS, Liu F, et al. (1999). The fetal cleft palate: II. Scarless healing after in utero repair of a congenital model. Plast Reconstr Surg104:1356–1364.
146.
Welch MP, Odland GF, Clark RA (1990). Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol110:133–145.
147.
Whitby DJ, Ferguson MW (1991). Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol147:207–215.
148.
Wijdeveld MG, Grupping EM, Kuijpers-Jagtman AM, Maltha JC (1987a). Mucoperiosteal migration after palatal surgery in beagle dogs. A longitudinal radiographic study. Int J Oral Maxillofac Surg16:729–737.
149.
Wijdeveld MG, Grupping EM, Kuijpers-Jagtman AM, Maltha JC (1987b). Wound healing of the palatal mucoperiosteum in beagle dogs after surgery at different ages. J Craniomaxillofac Surg15:51–57.
150.
Wijdeveld MG, Maltha JC, Grupping EM, De Jonge J, Kuijpers-Jagtman AM (1991). A histological study of tissue response to simulated cleft palate surgery at different ages in beagle dogs. Arch Oral Biol36:837–843.
151.
Williams JA (1992). Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors. Pathol Biol40:813–821.
152.
Xia P, Culp LA (1995). Adhesion activity in fibronectin’s alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp Cell Res217:517–527.
153.
Yamagishi S, Kobayashi K, Yamamoto H (1993). Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem Biophys Res Commun190:418–425.
154.
Yang CH, Liu CZ, Huang TF, Yang CM, Lui KR, Chen MS, et al. (1997). Inhibition of RPE cell-mediated matrix adhesion and collagen gel contraction by crovidisin, a collagen-binding snake venom protein. Curr Eye Res16:1119–1126.
155.
Yokozeki M, Moriyama K, Shimokawa H, Kuroda T (1997). Transforming growth factor-beta1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. Exp Cell Res231:328–336.
156.
Yokozeki M, Baba Y, Shimokawa H, Moriyama K, Kuroda T (1999). Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro. FEBS Lett442:61–64.
157.
Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG (1995). Saliva and growth factors: the fountain of youth resides in us all. J Dent Res74:1826–1832.
158.
Zhu YK, Liu XD, Skold MC, Umino T, Wang H, Romberger DJ, et al. (2001). Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol25:245–253.
